Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7SAA

Glycine and glutamate bound GluN1a-GluN2B NMDA receptors in non-active 1 conformation at 2.97 Angstrom resolution

7SAA の概要
エントリーDOI10.2210/pdb7saa/pdb
関連するPDBエントリー7SAB 7SAC 7SAD
EMDBエントリー24946 24947 24948 24949
分子名称Glutamate receptor ionotropic, NMDA 1, Glutamate receptor ionotropic, NMDA 2B, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total)
機能のキーワードligand-gated ion channel, ionotropic glutamate receptor, synaptic protein, voltage-gate ion channel, transport protein
由来する生物種Rattus norvegicus (Rat)
詳細
タンパク質・核酸の鎖数4
化学式量合計391716.91
構造登録者
Chou, T.-H.,Furukawa, H. (登録日: 2021-09-22, 公開日: 2022-07-20, 最終更新日: 2024-11-13)
主引用文献Chou, T.H.,Epstein, M.,Michalski, K.,Fine, E.,Biggin, P.C.,Furukawa, H.
Structural insights into binding of therapeutic channel blockers in NMDA receptors.
Nat.Struct.Mol.Biol., 29:507-518, 2022
Cited by
PubMed Abstract: Excitatory signaling mediated by N-methyl-D-aspartate receptor (NMDAR) is critical for brain development and function, as well as for neurological diseases and disorders. Channel blockers of NMDARs are of medical interest owing to their potential for treating depression, Alzheimer's disease, and epilepsy. However, precise mechanisms underlying binding and channel blockade have remained limited owing to challenges in obtaining high-resolution structures at the binding site within the transmembrane domains. Here, we monitor the binding of three clinically important channel blockers: phencyclidine, ketamine, and memantine in GluN1-2B NMDARs at local resolutions of 2.5-3.5 Å around the binding site using single-particle electron cryo-microscopy, molecular dynamics simulations, and electrophysiology. The channel blockers form different extents of interactions with the pore-lining residues, which control mostly off-speeds but not on-speeds. Our comparative analyses of the three unique NMDAR channel blockers provide a blueprint for developing therapeutic compounds with minimal side effects.
PubMed: 35637422
DOI: 10.1038/s41594-022-00772-0
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (2.97 Å)
構造検証レポート
Validation report summary of 7saa
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon